Patients’ Experiences and Perspectives of Receiving Written Medicine Information About Medicines: A Qualitative Study

References

• Gibbs S, Waters W, George C. The benefits of prescription information leaflets. Br J Clin Pharmacol. 1989;28(3):345–351. doi:10.1111/j.1365-2125.1989.tb05436.x
   Web of Science ®Google Scholar
• Nair K, Dolovich L, Cassels A, et al. What patients want to know about their medications. Focus group study of patient and clinician perspectives. Can Fam Physician. 2002;48:104–110.
   PubMed Web of Science ®Google Scholar
• Wongtaweepkij K, Krska J, Pongwecharak J, Jarernsiripornkul N. Experiences and views of medicine information among the general public in Thailand. Patient Prefer Adherence. 2020;14:1073–1082. doi:10.2147/PPA.S257454
   PubMed Web of Science ®Google Scholar
• Mai A, Aslani P. Impact of vietnamese written and verbal medicine information on vietnamese-speaking Australians’ knowledge and satisfaction. Br J Clin Pharmacol. 2007;64(4):527–535. doi:10.1111/j.1365-2125.2007.02968.x
   Web of Science ®Google Scholar
• Adepu R, Swamy M. Development and evaluation of patient information leaflets (PIL) usefulness. Indian J Pharm Sci. 2012;74(2):174. doi:10.4103/0250-474X.103857
   Web of Science ®Google Scholar
• Akour A, Bardaweel S, Awwad O, Al-Muhaissen S, Hussein R. Impact of a pharmacist-provided information booklet on knowledge and attitudes towards oral contraception among Jordanian women: an interventional study. Eur J Contracept Reprod Health Care. 2017;22(6):459–464. doi:10.1080/13625187.2017.1412425
   PubMed Web of Science ®Google Scholar
• Tong V, Raynor DK, Blalock SJ, Aslani P. Consumer interpretation of ramipril and clopidogrel medication risk information – implications for risk communication strategies. Patient Prefer Adherence. 2015;9:983–988. doi:10.2147/PPA.S86414
   Web of Science ®Google Scholar
• Caughey GE, Tait K, Vitry AI, Shakib S. Influence of medication risks and benefits on treatment preferences in older patients with multimorbidity. Patient Prefer Adherence. 2017;11:131–140. doi:10.2147/PPA.S118836
   PubMed Web of Science ®Google Scholar
• Herber OR, Gies V, Schwappach D, Thürmann P, Wilm S. Patient information leaflets: informing or frightening? A focus group study exploring patients’ emotional reactions and subsequent behavior towards package leaflets of commonly prescribed medications in family practices. BMC Fam Pract. 2014;15(1):163. doi:10.1186/1471-2296-15-163
   Web of Science ®Google Scholar
• Jarernsiripornkul N, Phueanpinit P, Pongwecharak J, Krska J. Experiences of and attitudes towards receiving information about non-steroidal anti-inflammatory drugs: a cross-sectional survey of patients in Thailand. Expert Opin Drug Saf. 2016;15(4):417–426. doi:10.1517/14740338.2016.1139571
   PubMed Web of Science ®Google Scholar
• Tong V, Raynor DK, Aslani P. Design and comprehensibility of over-the-counter product labels and leaflets: a narrative review. Int J Clin Pharm. 2014;36(5):865–872. doi:10.1007/s11096-014-9975-0
   Web of Science ®Google Scholar
• The Medicines and Healthcare Products Regulatory Agency. Best practice guidance on patient information best practice guidance on patient [Internet]. 2012. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/328405/Best_practice_guidance_on_patient_information_leaflets.pdf. Accessed October 14, 2020.
   Google Scholar
• Phueanpinit P, Pongwecharak J, Krska J, Jarernsiripornkul N. Medicine information leaflets for non-steroidal anti-inflammatory drugs in Thailand. Int J Clin Pharm. 2016;38(1):25–29. doi:10.1007/s11096-015-0220-2
   PubMed Web of Science ®Google Scholar
• Pongpunna S, Pratipanawatr T, Jarernsiripornkul N. Survey of outpatients’ use and needs of patient medicine information leaflets in Thailand. Int J Clin Pharm. 2019;41(1):140–150. doi:10.1007/s11096-018-0748-z
   Web of Science ®Google Scholar
• Wongsalap Y, Jedsadayanmata A. Trends and predictors of high-intensity statin therapy and LDL-C goal achievement among Thai patients with acute coronary syndrome. J Cardiol. 2020;75(3):275–281. doi:10.1016/j.jjcc.2019.08.012
   Web of Science ®Google Scholar
• Thai Atherosclerosis Society. RCPT clinical practice guideline on pharmacologic therapy of dyslipidemia for atherosclerotic cardiovascular disease prevention [Internet]. 2017. Available from: https://www.thaiathero.org/thaiatherodetail.php?id=102. Accessed November 1, 2020.
   Google Scholar
• Jose J. Statins and its hepatic effects: newer data, implications, and changing recommendations. J Pharm Bioallied Sci. 2016;8(1):23–28. doi:10.4103/0975-7406.171699
   PubMed Web of Science ®Google Scholar
• Jarernsiripornkul N, Phueanpinit P, Pongwecharak J, Krska J, Schouten B. Development and evaluation of user-tested Thai patient information leaflets for non-steroidal anti-inflammatory drugs: effect on patients’ knowledge. PLoS One. 2019;14(1):1–15. doi:10.1371/journal.pone.0210395
   Web of Science ®Google Scholar
• Raynor D, Silcock J, Knapp P, Edmondson H. How do patients use medicine information leaflets in the UK? Int J Pharm Pract. 2007;15(3):209–218. doi:10.1211/ijpp.15.3.0008
   Google Scholar
• Hamrosi KK, Aslani P, Raynor DK. Beyond needs and expectations: identifying the barriers and facilitators to written medicine information provision and use in Australia. Health Expect. 2014;17(2):220–231. doi:10.1111/j.1369-7625.2011.00753.x
   PubMed Web of Science ®Google Scholar
• Hammar T, Nilsson A-L, Hovstadius B. Patients’ views on electronic patient information leaflets. Pharm Pract (Granada). 2016;14(2):702. doi:10.18549/PharmPract.2016.02.702
   Google Scholar
• Division of Innovative Health Products and Services. Guideline for leaflet development for drug research and innovation [Internet]. 2019. Accessed October 14, 2020.
   Google Scholar
• Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13(1):117. doi:10.1186/1471-2288-13-117
   PubMed Web of Science ®Google Scholar
• Bawazir SA, Abou-Auda HS, Gubara OA, Al-Khamis KI, Al-Yamani MJMS. Public attitude toward drug technical package inserts in Saudi Arabia. J Pharm Technol. 2003;19(3):209–218. doi:10.1177/875512250301900302
   Google Scholar
• Basara LR, Juergens JP. Patient package insert readability and design. Am Pharm. 1994;34(8):48–53. doi:10.1016/s0160-3450(15)30339-1
   Google Scholar
• Wallace LS, Keenum AJ, Roskos SE, Blake GH, Colwell ST, Weiss BD. Suitability and readability of consumer medical information accompanying prescription medication samples. Patient Educ Couns. 2008;70(3):420–425. doi:10.1016/j.pec.2007.11.017
   PubMed Web of Science ®Google Scholar
• Piñero-López MÁ, Modamio P, Lastra CF, Mariño EL. Readability analysis of the package leaflets for biological medicines available on the internet between 2007 and 2013: an analytical longitudinal study. J Med Internet Res. 2016;18(5):e100. doi:10.2196/jmir.5145
   Web of Science ®Google Scholar
• Zarea Gavgani V, Mirzadeh-Qasabeh S, Hanaee J, Hamishehkar H. Calculating reading ease score of patient package inserts in Iran. Drug Healthc Patient Saf. 2018;10:9–19. doi:10.2147/DHPS.S150428
   Web of Science ®Google Scholar
• Nilnate W, Hengpraprom S, Hanvoravongchai P. Level of health literacy in Thai Elders, Bangkok, Thailand. J Health Res. 2016;30(5):315–321. doi:10.14456/jhr.2016.4
   Google Scholar
• Junkhaw T, Munisamy M, Samrongthong R, Taneepanichskul S. Factors associated with health literacy in suburban Bangkok type 2 diabetics (T2DM): a cross-sectional survey. J Med Assoc Thai. 2019;102(7):809–815.
   Google Scholar
• Raynor DK, Dickinson D. Key principles to guide development of consumer medicine information–content analysis of information design texts. Ann Pharmacother. 2009;43(4):700–706. doi:10.1345/aph.1L522
   PubMed Web of Science ®Google Scholar
• Dickinson D, Raynor DK, Duman M. Patient information leaflets for medicines: using consumer testing to determine the most effective design. Patient Educ Couns. 2001;43(2):147–159. doi:10.1016/S0738-3991(00)00156-7
   Web of Science ®Google Scholar
• Webster RK, Weinman J, Rubin GJ. How does the side-effect information in patient information leaflets influence peoples’ side-effect expectations? A cross-sectional national survey of 18- to 65-year-olds in England. Health Expect. 2017;20(6):1411–1420. doi:10.1111/hex.12584
   PubMed Web of Science ®Google Scholar
• Krska J, Morecroft CW. Patients’ use of information about medicine side effects in relation to experiences of suspected adverse drug reactions: a cross-sectional survey in medical in-patients. Drug Saf. 2013;36(8):673–680. doi:10.1007/s40264-013-0065-3
   PubMed Web of Science ®Google Scholar
• Vinker S, Eliyahu V, Yaphe J. The effect of drug information leaflets on patient behavior. Isr Med Assoc J. 2007;9(5):383–386.
   PubMed Web of Science ®Google Scholar
• Garrud P, Wood M, Stainsby L. Impact of risk information in a patient education leaflet. Patient Educ Couns. 2001;43(3):301–304. doi:10.1016/s0738-3991(00)00168-3
   Web of Science ®Google Scholar
• American Society of Health-System Pharmacis. ASHP guidelines on pharmacist-conducted patient education and counseling. Am J Health Syst Pharm. 1997;54(4):431–434. doi:10.1093/ajhp/54.4.431
   Google Scholar
• Phueanpinit P, Pongwecharak J, Sumanont S, Krska J, Jarernsiripornkul N. Physicians’ communication of risks from non-steroidal anti-inflammatory drugs and attitude towards providing adverse drug reaction information to patients. J Eval Clin Pract. 2017;23(6):1387–1394. doi:10.1111/jep.12806
   Web of Science ®Google Scholar
• Lee K, Hoti K, Hughes JD, Emmerton L. Dr google and the consumer: a qualitative study exploring the navigational needs and online health information-seeking behaviors of consumers with chronic health conditions. J Med Internet Res. 2014;16(12):e262. doi:10.2196/jmir.3706
   PubMed Web of Science ®Google Scholar